ARTICLE | Company News
Artes Biotechnology, Q Chip deal
May 10, 2010 7:00 AM UTC
The companies partnered to develop monthly sustained-release formulations of interferon alpha 2a to treat HCV and HBV. The partners will evaluate Q Chip's Q-Sphera peptide and protein delivery technol...